GlaxoSmithKline rejected three offers, saying they “undervalued” its consumer goods business.
This entry was posted
on Sunday, January 16th, 2022 at 7:01 am and is filed under Business.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.